Second, one study that performed the proteomic analysis of CSF revealed a decrease in seven CSF proteins in the AD patients; among these, four carry neuroprotective actions, while the remaining three proteins, including CDK5, promote neuronal death [56], suggesting that CDK5 may be considered a biomarker for AD, at least in CSF. This evidence concerns the gene CDK5 and Alzheimer disease.